Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
International Journal of Molecular Sciences|May 6, 2020
Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal SequestrationMaria Krchniakova, Jan Skoda, Jakub Neradil, et al.International Journal of Molecular Sciences|January 6, 2018
Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to RetinoidsPetr Chlapek, Viera Slavikova, Pavel Mazanek, et al.International Journal of Molecular Sciences|January 11, 2022
Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in NeuroblastomaPeter Macsek, Jan Skoda, Maria Krchniakova, et al.Cellular & Molecular Biology Letters|March 27, 2024
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and diseasePetr Pleskač, Christine A Fargeas, Renata Veselska, et al.Frontiers in Pharmacology|September 26, 2022
Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cellsMaria Krchniakova, Silvia Paukovcekova, Petr Chlapek, et al.Oncology Reports|March 5, 2015
DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: the same outcome of treatment with different doses in sensitive cell linesJakub Neradil, Gabriela Pavlasova, Martin Sramek, et al.Plos One|February 24, 2017
Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroupsPetr Chlapek, Karel Zitterbart, Leos Kren, et al.Journal of Experimental & Clinical Cancer Research : CR|May 13, 2010
Enhancement of ATRA-induced differentiation of neuroblastoma cells with LOX/COX inhibitors: an expression profiling studyPetr Chlapek, Martina Redova, Karel Zitterbart, et al.Cancer Cell International|June 25, 2014
The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expressionPetr Chlapek, Jakub Neradil, Martina Redova, et al.International Journal of Molecular Sciences|August 12, 2022
Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid TumorsSilvia Paukovcekova, Maria Krchniakova, Petr Chlapek, et al.Pageof 6